NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry dataFirst published 30/09/2020 Last updated 23/04/2024 EU PAS number: EUPAS37258StudyOngoing